Skip to main content
  • Equitably Harnessing The Power of Health Data

    There has always been a challenge on collaborations and strategic partnerships can harness the power of data. Further more a question is asked how they can use the data to tackle the most devastating health issues. 

    The COVID-19 pandemic has highlighted the critical importance of generating rigorous evidence for decision-making. To bring equity the global health research community needs to find ways to equitably unite and generate actionable insights from data.

  • New Data Sharing e-Learning Course - First Two Modules Released

    Expectation from health research funders, regulatory agencies, and journals for sharing of de-identified individual-level health research data is now increasing. 

    Arguments in favour of data sharing include maximising the utility of the data, improving research transparency and allowing confirmation of the interpretation of results, with the overall goal of improving science and health. However, the volume of data shared remains low. This has been partially attributed to lack of data management capacity and lack of knowledge of how and where to share data. 

  • Uganda Successfully Launches Trials For Coronavirus Drug

    Uganda has launched clinical trials of a locally produced herbal treatment for COVID-19. The therapeutic drug was developed by a think-tank of local scientists - under the Presidential Initiative on Epidemics. The product: UBV-01N is the first Ugandan natural chemotherapeutic medicine to go through an international level of the clinical trial process.

  • UVRI Hosts Inaugural CCP Study Training

    Uganda Virus Research Institute(UVRI) conducted a Clinical Characterization Protocol(CCP) training for COVID-19 on 25th January 2021. It is a sub study of a clinical and molecular epidemiology of severe acute febrile and respiratory illness in Uganda.